CAS No. 82571-53-7 | Ozagrel
CAS No. 82571-53-7 | Ozagrel
CAS No. 82571-53-7 | Ozagrel
CAS No. 82571-53-7 | Ozagrel
+
  • CAS No. 82571-53-7 | Ozagrel
  • CAS No. 82571-53-7 | Ozagrel
  • CAS No. 82571-53-7 | Ozagrel
  • CAS No. 82571-53-7 | Ozagrel

CAS No. 82571-53-7 | Ozagrel

Name: Ozagrel CAS No. 82571-53-7 MF:C13H12N2O2 MW:228.25 Purity:99% Package: 10g,25g,50g,100g,250g Worldwide Delivery

Categories:

Biochemicals

Product introduction

Introduction and application of  CAS No. 82571-53-7 | Ozagrel

 

Synonyms:(E)-4-(1-Imidazoylmethyl)cinnamicacid;

2-Propenoicacid,3-[4-(1H-imidazol-1-ylmethyl)phenyl]-,(2E)-;

(E)-3-[4-(1H-Imidazol-1-ylmethyl)phenyl]propenoicacid;

(E)-3-[p-(1H-Imidazol-1-ylmethyl)phenyl]acrylicacid;

3-[4-(1H-IMIDAZOL-1-YLMETHYL)PHENYL]-2E-PROPENOICACID;

OzagrelAPI;

Ozagrel(OKY-046);

(2E)-3-[4-(1H-imidazol-1-ylmethyl)phenyl]-2-propenoicacid

 

Specification:

ITEMS

SPECIFICATION

CAS

82571-53-7

MF

C13H12N2O2

MW

228.25

Melting point

223-224°

Boiling point

468.0±25.0 °C

Density

1.17±0.1 g/cm3

Acidity coefficient

4.43±0.10

Solubility

DMSO: 50 mg/mL (219.06 mM; requires ultrasound)

Form

Powder

Storage condition

Sealed in dry,Room Temperature

use:

Powerful thromboxane synthase inhibitor. By inhibiting thromboxane synthase, it reduces thromboxane A (TXA2) in the body and promotes the production of prostacyclin (PGl2) to combat platelet aggregation and cerebral vascular spasm, while it inhibits cyclooxygenase and other arachidonic enzymes. Acid metabolizing enzymes have little effect. It is clinically used to improve cerebral spasm after subarachnoid hemorrhage, cerebral ischemia symptoms associated with cerebral spasm, and movement disorders associated with the acute phase of cerebral thrombosis.

production method:

Using p-tolubenzaldehyde as the raw material, it undergoes aldol condensation with acetic anhydride and then dehydrates to generate 3-p-tolylacrylic acid, which is ethyl esterified into 3-p-tolylacrylic acid ethyl ester, and benzoyl peroxide is used as the initiator. Use N-bromosuccinimide (NBS) to brominate the methyl group on the ring to bromomethyl, then react with imidazole and then hydrolyze to form sodium ozagrel, with a melting point of 308°C (decomposition).

 

Package and transportation :

Package: 10g,25g,50g,100g,250g

Transportation: by courier/ by air/ by sea

Key words:

Related Products

Related Products

Inquiry

SUBMIT